Your latest cannabis business info from Europe

Your latest cannabis business info from Europe


UK ban on sales of more than 400 CBD products

According to the Food Standards Agency, more than 400 CBD products will need to be taken off the UK market. They failed to comply with the Novel Food laws. Manufacturers and merchants of CBD products have received a letter from the FSA. It was informing them that the in question goods cannot be sold legally in the UK. Businesses have until March 31 to submit complete Novel Food authorisation applications, failing which they must stop selling such goods.

Why was a ban on over 400 CBD products imposed in the UK?

All CBD products supplied in the UK must comply with the Novel Food laws. These went into force in March 2021. Novel Food registrations must be of satisfactory status. This is done to guarantee that the goods are safe to eat and have the right amounts of CBD. The FSA has taken measures to remove non-compliant goods from the market since many CBD manufacturers have disregarded the rules.

There are a few reasons why some CBD producers did not follow the UK’s Novel Food rules. The restrictions were only put into force in March 2021, which is one reason why some businesses might not have been aware of the specifications or the compliance deadlines. Another factor is that getting a Novel Food Authorization can be a difficult and long procedure. Companies are required to submit to the FSA for review full details about their products, including information on their safety, composition, and intended usage. This can take several months and involves a considerable time and resource commitment.

It’s also possible that some CBD producers were hesitant to follow the rules because they were worried about how it would affect their company. Due to the high cost of compliance, some businesses may have been unable or unwilling to make the necessary research and testing investments.

What are the consequences?

After March 31st, the FSA has threatened to take enforcement action against businesses that continue to market non-compliant goods. This can include penalties and legal action. Consumers have also been advised by the FSA to exercise caution when buying CBD products and to only buy items that have a valid Novel Food application.

The UK CBD industry is anticipated to be significantly impacted by the withdrawal of these goods from the market. Up to 50% of CBD products now on the UK market are thought to be in violation of the Novel Food laws. In the short term, this can cause a shortage of CBD products and possibly raise costs.

Numerous people in the CBD sector have criticized the FSA’s strategy for enforcing the Novel Food laws. They contend that the rules are unclear and that the FSA has not given enough instructions. Some people are also worried that the restrictions’ enforcement would unfairly affect smaller enterprises and lead to job losses. Despite the criticism, the FSA has stressed that the Novel Food laws must be enforced. It is in order to guarantee consumer protection and legal operation of the CBD industry. The FSA has also made it clear that it will keep collaborating with the sector to support businesses in adhering to rules and guarantee that consumers in the UK have access to safe and authorized CBD products.


Future of cannabis beverages market in Europe

Netherlands: transition phase of coffee shop experiment in June


Germany: protection zones with the “Bubatzkarte”

Promising future of medical cannabis in Spain: €335 Million by 2030